Low-value proton pump inhibitor prescriptions among older adults at a large academic health system

Journal of the American Geriatrics Society Dec 13, 2019

Mafi JN, May FP, Kahn KL, et al. - Given that proton pump inhibitor (PPI)-related complications especially tend to happen in older adults, therefore, with a goal to inform quality improvement intervention, researchers characterized the prevalence of potentially low-value PPI prescriptions among older adults by analyzing a cohort of 399 patients, aged 65 years or older, currently prescribed PPIs, and comprising 63.9% female. The mean age of the study sample was 76.2 years. Findings revealed that a PPI was prescribed to one in eight older adults, and over one-third of prescriptions were potentially low-value. Most often, the absence of long-term indications was identified as the reason for appropriate short-term prescriptions becoming potentially low value. They noted that most potentially low-value prescribing was concentrated in a small subset of primary care physicians, the implementation of interventions targeting them and/or applying electronic health record-based automatic stopping rules may protect older adults from harm.
Go to Original

Sign-up to continue reading. It is free & takes less than 2 mins

  • 45 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Free & unlimited access to original articles and quizzes
  • Nonloggedinlock icon
    Secure: we never sell your data
This article is only available to members. Are you a doctor? Click here to signup for free.
Try M3 India / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen